
|Articles|June 1, 2008
- Volume 0 0
NYCOMED MERGES WITH BRADLEY PHARMACEUTICALS
Advertisement
Nycomed US Inc recently completed its acquisition of Bradley Pharmaceuticals, a company focused on niche therapeutic markets in the United Sates. Nycomed will expand the line of dermatology products currently offered through its PharmaDerm Division. The company also expects that the purchase will provide an enhanced platform for in-licensing and copromotion of dermatology products.
Articles in this issue
over 17 years ago
can you READ these Rxs?over 17 years ago
Case Studiesover 17 years ago
ASTHMA WATCHover 17 years ago
CHOLESTEROL WATCHover 17 years ago
ARTHRITIS WATCHover 17 years ago
WOMEN'S HEALTH WATCHover 17 years ago
DIABETES WATCHover 17 years ago
compounding HOTLINEover 17 years ago
pharmacy TECHNOLOGY newsover 17 years ago
pharmacy TECHNOLOGY productsNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Enfortumab Vedotin Plus Pembrolizumab Shows Promise as a Platinum-Free Option in Earlier Bladder Cancer
2
FDA Approves Amivantamab and Hyaluronidase-lpuj, Revolutionizing Lung Cancer Treatment With 5-Minute Subcutaneous Delivery
3
Advancing the Role of Pharmacy Technicians in Hazardous Drug Compounding
4
Notable Updates in Medication Therapy Management in 2025
5









































































































































































































